King Pharmaceuticals, Inc. (KG)
$11.44
0.14 (+1.24%)
| CAPS Rating |
|
|---|---|
| Open | $11.41 |
| Previous Close | $11.30 |
| Daily Range | $11.28 - $11.55 |
| 52-Week Range | $5.86 - $13.20 |
| Market Cap | $2.84B |
| P/E Ratio | 5.87 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 3,185,560 |
| Average Daily Volume | 0 |
KG
VS S&P 500 (SPY)
How do you think KG will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
KG Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
KG News and Commentary
- UPDATE 1-King conducting review of animal health business – Reuters
- DARA Set to Sky Rocket by Thursday – Blog at The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- DARA—Time to Harvest – Blog at The Motley Fool
- UPDATE 1-King sues ZymoGenetics alleging trademark violation – Reuters
- UPDATE 1-FDA declines to approve King's heart imaging drug – Reuters
- UPDATE 1-US FDA: King pain drug videos misleading – Reuters
- 5 Top Stocks at Half Price – The Motley Fool
- LGND Oversold – Blog at The Motley Fool
- 5 Stocks That Laugh at Wall Street – The Motley Fool
- Hisamitsu Buys Noven; Salonpas Strengthens Topical Analgesic Presence [JNJ,CHTT,KG] – Blog at The Motley Fool
- Obama's FDA Polices Future OTC Topical Analgesics [KG, JNJ, CHTT, NRI, ENDP] – Blog at The Motley Fool
- ZymoGenetics Goes in for the Kill – The Motley Fool
- The Real King of the Drug Pushers – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- Stock Review: Pain Therapeutics (PTIE) – Blog at The Motley Fool
- REMS: Not Just for Sleeping Anymore – The Motley Fool
- ETFs for an Uncertain Future – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
RSS Headlines
Fool UK
